Viatris And FKB Introduce First Japanese Adalimumab Biosimilar
Rival To Humira Launched Following Approval Last June
Viatris and Fujifilm Kyowa Kirin Biologics have introduced Japan’s first biosimilar rival to Humira.

Viatris and Fujifilm Kyowa Kirin Biologics have introduced Japan’s first biosimilar rival to Humira.